The healthcare landscape is undergoing a structural shift. As digital transformation moves from theory to execution, the health.tech 2026 Global Summit served as the central meeting point for the entire innovation ecosystem – startups, clinicians, pharma leaders, and investors – dedicated to translating innovative ideas into real-world patient outcomes.
Building on the momentum of its previous editions in Munich, health.tech has evolved into a global platform through a joint venture between Bits & Pretzels and MCH Group. By relocating to Basel, home to industry giants like Roche and Novartis, the 2026 summit created Europe’s densest environment for healthcare technology and investment.
For tSoulmates Ventures, attending health.tech was about more than scouting; it was about aligning with founders who are navigating the rigid constraints of the MDR and the AI Act to build a more resilient healthcare future.
Our visit reinforced our commitment to supporting startups that don’t just innovate, but execute. Our participation in Basel has resulted in a refined perspective on the current market and a shortlist of founders whose vision aligns with our investment criteria.